Altshuler Shaham’s iRadimed IRMD Stock Holding History

Altshuler Shaham’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-42	Closed	-$4.04K	–	517
2026 Q1	$4.04K	Buy	+42	New	+$4.2K	﹤0.01%	317
2025 Q4	–	Sell	-60	Closed	-$4.27K	–	434
2025 Q3	$4.27K	Buy	+60	New	+$4K	﹤0.01%	282
2025 Q2	–	Sell	-72	Closed	-$3.78K	–	343
2025 Q1	$3.78K	Buy	+72	New	+$4.04K	﹤0.01%	258
2023 Q4	–	Sell	-475	Closed	-$21.1K	–	289
2023 Q3	$21.1K	Sell	475 -103	-18%	-$4.79K	﹤0.01%	245
2023 Q2	$27.6K	Buy	+578	New	+$26.1K	﹤0.01%	257
2022 Q2	–	Sell	-826	Closed	-$37K	–	504
2022 Q1	$37K	Buy	+826	New	+$38.2K	﹤0.01%	446
2019 Q1	–	Sell	-315	Closed	-$8K	–	323
2018 Q4	$8K	Buy	+315	New	+$8.46K	﹤0.01%	199

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Altshuler Shaham's IRMD Position: Q2 2026 in Review

Altshuler Shaham sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 42 shares — an estimated $4.04K sold.

Altshuler Shaham first reported a position in IRMD in Q4 2018 and held it in 7 quarters. The position peaked at $37K in Q1 2022. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Altshuler Shaham reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
Altshuler Shaham sold 42 iRadimed shares in Q2 2026, an estimated $4.04K.
Altshuler Shaham first reported a position in iRadimed in Q4 2018 and held it in 7 quarters.
Altshuler Shaham's iRadimed position peaked at $37K in Q1 2022.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.